Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Cardiotoxicity 2Breast Neoplasms 2Ventricular Dysfunction 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Acute 1Heart Failure 1Brain Neoplasms 1

Interventions

pegfilgrastim 1dapagliflozin 1Vincristine 1Standard of Care 1Rituximab 1Prednisolone 1Lenalidomide 1Ivabradine 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1Carvedilol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Heart Failure × Carvedilol × Clear all
NCT01724450 2018-02-05

Ceccy

University of Sao Paulo

Phase 3 Completed
200 enrolled
Breast

Breast Neoplasms, Heart Failure, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡